Inogen (INGN) revenue and earnings history
Inogen reported revenue of $349M for fiscal 2025 (year ended Dec 31, 2025), +3.9% on the year before, and net income of −$22.7M.
Over 13 years, from fiscal 2012 to fiscal 2025, revenue grew at a compound rate of +16.4% a year.
Revenue and net income, 14 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $349M+3.9% | −$30.2M | −$22.7M | −$11.2M | $2.52M | −$13.7M | $8.01M | — | — | $104M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Inogen (INGN) on OQRO.
Common questions
What was Inogen's revenue in fiscal 2025?
$349M for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 27, 2026. That is +3.9% on fiscal 2024 ($336M).
How fast has Inogen's revenue grown?
From $48.6M in fiscal 2012 to $349M in fiscal 2025: a compound annual growth rate of +16.4% over 13 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Inogen been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Inogen tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
